Effect of a lactate-guided conditioning program on heart rate variability obtained using 24-Holter electrocardiography in Beagle dogs.

The dogs' responses to training exercise are seldom monitored using physiological variables, and cardiac autonomic regulation (CAR) is a relevant determinant of endurance-training adaptation. There are studies in the literature establishing that regular exercise could interfere with CAR in dogs, measured by heart rate and vagal-derived indexes of heart-rate-variability (HRV). However, few studies were found using a prescribed training program based on the lactate threshold (LT) to determine HRV by a 24-h Holter analysis. The purpose of this study was to test whether an endurance-training program (ETP) guided individually by LT raises time-domain measures of HRV in healthy Beagle dogs. Twenty dogs were assigned to two groups: control (C) and trained (T). The dogs from group T underwent an incremental exercise test (IET) to determine their LT. Both LT and velocity corresponding to the LT (VLT) was determined by visual inspection. T group performed an eight-week endurance-training program consisting of treadmill runs set to 70-80% of the VLT. Next, dogs from the group T have submitted to IET again. The maximal velocities (Vmax) at which achieved by the trained dogs in both IETs were determined. The group S did not undergo IETs or ETP. HRV was determined by the 24-hour-Holter at rest, before and on the 2°, 4°, 6° and 8° training weeks. To examine the HR impact on HRV, standard HRV variables were normalized to prevailing HR. VLT and Vmax rose in group T, indicating an improvement of dogs' aerobic and anaerobic capacity. The normalized standard HRV indexes were relatively attenuated since these variables had a reduction in the degree of correlation concerning an average HR. The ETP resulted in decreased resting heart rate and increased time-domain indices, highlighting the log-transformed square root of the mean sum of the squared differences between R-R intervals (Ln rMSSD). The lactate-guided endurance-training program could lead to better parasympathetic cardiac modulation in Beagle dogs.

Lactate and glucose thresholds and heart rate deflection points for Beagles during intense exercise.

OBJECTIVE To determine whether the lactate threshold of dogs could be determined by a visual method and to assess the extent of agreement and bias among treadmill velocities for the lactate threshold as determined by visual (LTv) and polynomial (LTp) methods, glucose threshold as determined by visual (GTv) and polynomial (GTp) methods, and heart rate deflection point (HRdp) as a method for estimating the aerobic capacity of dogs. ANIMALS 18 healthy adult Beagles. PROCEDURES Each dog underwent a standardized incremental treadmill exercise test once. The test ended when the dog began to show signs of fatigue. Plasma lactate and glucose concentrations and heart rate (HR) were plotted against exercise intensity (treadmill velocity) for the duration of the test, and the LTv, GTv, and HRdp were determined visually. The LTp and GTp were determined by means of a second-order polynomial function. One-way ANOVA, Pearson correlation, Bland-Altman analyses, and ordinary least products regression were used to assess the extent of agreement and bias among the various threshold velocities. RESULTS Mean velocity did not differ significantly among the thresholds evaluated. There was a strong positive correlation between the LTv velocity and the velocity for GTv (r = 0.91), LTp (r = 0.96), GTp (r = 0.94), and HRdp (r = 0.95). CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that LTv could be determined for dogs undergoing intense exercise on a treadmill, and the treadmill velocity corresponding to the LTv was associated with the velocity for the other hallmarks of endurance. Thus, that method may be useful for prescription and evaluation of conditioning programs for dogs.

Weight loss improves arterial blood gases and respiratory parameters in obese dogs.

Canine obesity is a common medical disorder and a known risk factor for associated diseases; it can seriously influence various physiological functions, thereby limiting the longevity of the animal. In this study, we evaluated potential respiratory alterations in obese dogs before and after being subjected to caloric restriction to decrease their body weight by 20%, and compared those dogs with control dogs with ideal body condition score. The animals were divided into three experimental groups: GI (obese dogs; n = 11); GII (obese dogs after weight loss, same animals as in GI); GIII (control dogs; n = 11). We evaluated lung function by spirometry and arterial blood gases. Statistical analysis included paired or non-paired Student's t test. Compared with dogs within an ideal body condition score (GIII), obese dogs (GI) had a low arterial partial pressure of oxygen (p < 0.05); decreased tidal volume (p < 0.005), inspiratory time and expiratory time (p < 0.05); and an increased respiratory rate (p < 0.005). After losing weight (GII), no differences with control dogs (GIII) were verified. The results suggested that obese dogs have an improvement in respiratory function with weight loss, but further investigations in a larger group of dogs are advised to confirm these findings.

Cardiorespiratory evaluation of brachycephalic syndrome in dogs / Avaliação cardiorespiratória da síndrome braquiocefálica em cães

Brachycephalic syndrome (BS) in dogs is characterized by the combination of primary and secondary upper respiratory tract abnormalities and may result in significant upper airway obstruction. It can trigger inspiratory dyspnea, culminating in secondary respiratory distress, soft tissue edema, upper airway obstruction, turbulent airflow, inspiratory noise, and even death. These changes lead to increased resistance of the air passages, which can cause elevation of pulmonary pressure and clinical manifestations attributable to pulmonary hypertension. The consequence is right-sided cardiac remodeling (Cor pulmonale) with possible progression to right congestive heart failure. To investigate the effects of BS on the cardiovascular system, 28 animals were recruited for a prospective study and assigned to either the Brachycephalic Group (BG), composed of 22 French bulldogs with BS or the Control Group (CG), which was composed of 6 healthy Beagle dogs. All animals underwent a detailed physical examination, as well as laboratory analyses, electrocardiography, echocardiography, chest radiography and indirect measurement of systemic arterial blood pressure. The most relevant finding was a lower PaO2 (90.6±12.9mmHg) in BG as compared to CG (104.9±5.2), (p≤0.05), possibly attributable to hypoventilation due to anatomical alterations.(AU)

A síndrome braquicefálica (BS) é caracterizada pela combinação de anormalidades primárias e secundárias do trato respiratório superior em cães, podendo resultar em obstrução significativa das vias aéreas superiores. Pode desencadear dispneia inspiratória, culminando em dificuldade respiratória secundária, edema de tecidos moles, obstrução das vias aéreas superiores, fluxo de ar turbulento, ruído inspiratório e até morte. Essas alterações levam ao aumento da resistência da passagem do ar, o que pode causar elevação da pressão pulmonar e manifestações clínicas atribuídas à hipertensão pulmonar. A consequência é o remodelamento cardíaco do lado direito (Cor pulmonale) com possível progressão para insuficiência cardíaca congestiva direita. A fim de averiguar os efeitos da BS sobre o sistema cardiovascular, 28 animais foram recrutados para um estudo prospectivo e distribuídos em Grupo Braquicefálico (GB), composto por 22 Bulldogs franceses com síndrome braquicefálica ou Grupo Controle (GC), composto por 6 cães Beagles saudáveis. Todos os animais foram submetidos a exame físico detalhado, bem como análises laboratoriais, eletrocardiografia, ecocardiografia, radiografias torácicas e mensuração indireta de pressão arterial sistêmica. Os achados mais relevantes foram relacionados ao GB (90,6±12,9mmHg) com menor PaO2 em relação ao GC (104,9±5,2), (p≤0,05), possivelmente atribuível à hipoventilação, em decorrência das alterações anatômicas.(AU)

Influence of estrous cycle and gestation on cardiovascular system of bitches.

The purpose of this study was to evaluate the consequences of the estrous cycle and gestation on the cardiovascular system of bitches evaluated through echocardiographic assessment. Fifteen healthy pregnant bitches aged 2 to 6 years and weighing 8.8 ±â€¯2.5 kg were included in the study. Heart rate and blood pressure were clinically evaluated. M-mode, spectral, and tissue Doppler-echocardiography assessments were performed during the anestrous and estrous stages, every 15 days during pregnancy (15, 30, 45, and 60 days), and 45 days postpartum. The data for evaluated variables were submitted for statistical analysis. Heart rate (P = 0.286) and systolic blood pressure (P = 0.686) were not changed as a result of pregnancy or estrus, while ejection fraction (P = 0.0016) and fractional shortening (P = 0.00004) changed. The variables transmitral flow, isovolumetric relaxation time, aortic and pulmonary flow, and some variables related to myocardium movement obtained via tissue Doppler assessment varied (P < 0.05) among the reproductive periods studied. In conclusion, gestation resulted in changes in echocardiography variables, and consequently, on maternal hemodynamics, with myocardial contractility increasing during pregnancy, resulting in greater systolic efficiency and ventricular compliance.

Matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathy / Metaloproteinases de matriz 2 e 9 em coelhos com cardiomiopatia induzida pela doxorrubicina

Some studies have shown the role played by matrix metalloproteinases and their inhibitors in doxorubicin cardiotoxicity. In this study, we sought to investigate how plasma and myocardial MMP 2 and 9 perform in rabbits with doxorubicin-induced cardiomyopathy, searching for a correlation between the activity of these collagenases and cardiac remodeling. Cardiomyopathy was induced by doxorubicin given intravenously twice a week for six consecutive weeks. Plasma MMP activity and the echocardiogram were assessed at baseline, and at 15 and 45 days after first injection of doxorubicin. The myocardial activity of these enzymes was solely evaluated in nine rabbits at 45 days, and results were compared with nine healthy controls. We only identified the full-length forms of both MMP 2 and 9 throughout the study. The plasma pro-MMP 2 reduced along the deterioration of cardiac function, while the pro-MMP 9 increased significantly at T45 as compared to baseline and T15. A negative significant correlation was found to exist between the plasma activity of pro-MMP 2 and mitral E-to-mitral septal annular early diastolic velocity ratio, which is an estimate of mean left atrial pressure and congestion. Only pro-MMP 2 was found in myocardial samples, and mean activity of such enzyme was statistically lower than that recorded for healthy controls. Although no active form was documented for either collagenase, the duration of the treatment with doxorubicin played a role in the alteration of plasma pro-forms activity. However, these changes could not be associated with most echocardiographic parameters that are supportive of cardiac remodeling.(AU)

Alguns estudos já demonstraram o papel exercido pelas metaloproteinases de matriz e seus inibidores na cardiotoxicidade promovida pela doxorrubicina. Assim, este estudo teve como objetivo investigar o comportamento das MMPs 2 e 9 plasmáticas e miocárdicas em coelhos com cardiomiopatia induzida pela doxorrubicina, buscando determinar se há correlação entre a atividade dessas colagenases e o remodelamento cardíaco. A cardiomiopatia foi induzida pela doxorrubicina aplicada por via intravenosa duas vezes por semana ao longo de seis semanas consecutivas. A atividade plasmática das MMPs e o ecocardiograma foram avaliados no momento basal e aos 15 e 45 dias após a primeira aplicação da doxorrubicina. A atividade miocárdica dessas enzimas foi quantificada em apenas nove coelhos aos 45 dias e os resultados comparados com outros nove controles saudáveis. Foram identificadas apenas as formas inativas das MMPs 2 e 9 durante todo o estudo. A pro-MMP 2 plasmática reduziu à medida que a função cardiaca se deteriorou, enquanto a pro-MMP 9 aumentou significativamente em T45 quando comparada aos momentos basal e T15. Houve correlação negativa significativa entre a atividade plasmática da pro-MMP 2 e a relação entre E mitral e a velocidade anular mitral no início da diástole, um parâmetro que permite estimar a pressão atrial esquerda média e a congestão. Apenas a pro-MMP 2 foi documentada nas amostras miocárdicas dos coelhos com cardiomiopatia e atividade media dessa enzima foi estatisticamente menor que aquela observada nos controles saudáveis. Embora a forma ativa de ambas as colagenases não tenha sido identificada, o tempo de tratamento com doxorrubicina interferiu na atividade das formas inativas plasmáticas. Contudo, essas alterações não se associaram com a maioria dos parâmetros ecocardiográficos que indicam remodelamento cardíaco.(AU)

Cardiac parameters during the estrous cycle of canine bitches / Parâmetros cardíacos durante o ciclo estral de cadelas

The cardiovascular parameters of canine bitches were assessed during the estrous cycle. A total of eleven mongrel female dogs were enrolled in a longitudinal prospective investigation. Six animals were bred during the study and were assigned into group I, in which evaluations were performed during proestrus, estrus, gestational diestrus and anestrus. The five remaining bitches were not bred and underwent evaluations during proestrus, estrus, nongestational diestrus and anestrus. The holter data showed a gradual increase in the minimum and mean heart rate along pregnancy, as well as a reduction during anestrus, which differed significantly among the distinct periods. The values for maximal heart rate documented during pregnancy were significantly lower than those recorded during anestrus, and a variation in the heart rate circadian rhythm was also found, as demonstrated by decreases at night and rises during the day. Cardiac rhythm had a similar performance in both pregnancy and anestrus. Likewise, the blood pressure, electrocardiography, and echocardiography data did not vary during the estrous cycle. The results support the role played by the autonomic nervous system during these two distinct periods in order to attain a heart rate that provides the blood needed by the female's body during the various stages of the reproductive cycle. Further studies are needed to better clarify the cardiovascular compensatory neuroendocrine events that accompany gestation in this species.(AU)

Os parâmetros cardiovasculares de fêmeas caninas foram avaliados durante o ciclo estral. Um total de onze cadelas sem raça definida foram incluídas nesta pesquisa prospectiva longitudinal. Seis animais foram colocados em reprodução durante o estudo e avaliados durante o proestro, estro, diestro gestacional e anestro. As cinco cadelas restantes não se reproduziram e foram avaliadas durante o proestro, estro, diestro não gestacional e anestro. Os dados derivados do holter indicaram aumento gradativo nas frequências cardíacas mínima e média durante a gestação, bem como redução durante o anestro, diferindo significativamente entre os distintos períodos. Os valores da frequência cardíaca máxima documentados durante a gestação foram significativamente inferiores àqueles registrados durante o anestro. Também foi identificada variação no ritmo circadiano da frequência cardíaca, conforme demonstrado por sua redução à noite e elevação durante o dia. No entanto, o ritmo cardíaco se comportou de modo semelhante tanto na gestação quanto no anestro. Da mesma forma, os dados de pressão sanguínea, eletrocardiografia e ecocardiografia não variaram durante o ciclo estral. Os resultados atestam o papel desempenhado pelo sistema nervoso autônomo ao longo desses dois períodos distintos, visando manter uma frequência cardíaca que garanta o suprimento sanguíneo necessário pelo organismo da fêmea durante os vários estágios do ciclo reprodutivo. Estudos adicionais são necessários para esclarecer mais detalhadamente os eventos neuroendócrinos e cardiovasculares compensatórios que acompanham a gestão nessa espécie.(AU)

Determination of left atrial volume in healthy dogs and dogs with myxomatous mitral valve disease / Determinação do volume atrial esquerdo em cães sadios e portadores da degeneração mixomatosa da válvula mitral

The left atrial volume (LAV) can be obtained using the biplane Simpson's method via echocardiography. Although in medicine this parameter has been considered to be a prognostic marker of left atrial enlargement in several cardiac diseases, in dogs with myxomatous mitral valve degeneration (MMVD), a valvulopathy characterized by left atrial (LA) volume overload, atrial enlargement is usually assessed by the LA-to-Aorta ratio (LA:Ao). Therefore, the body surface area (BSA)-indexed LAV was measured in healthy dogs and in dogs with MMVD using the biplane Simpson's method. For this purpose, a total of 107 healthy dogs (control) and 81 dogs with MMVD in ACVIM stages B1, B2 and C were assessed, with LAV being calculated during atrial diastole (d) and systole (s) through the biplane Simpson's method. Two-dimensional apical four-chamber (4C) and two-chamber (2C) images were obtained in every dog through the left parasternal window. The values obtained from healthy dogs were correlated with body weight using Pearson's test. An analysis of variance (ANOVA) and Tukey's test were used to compare healthy and MMVD dogs, as well as to investigate differences according with MMVD stages. A strong positive correlation was documented between either LAVd (r> 0.77) or LAVs (r> 0.73) and body weight in healthy dogs. The BSA-indexed LAV calculated for MMVD dogs was significantly different (p<0.01) from that obtained for the control group. Also, LAV was significantly different (P<0.05) when stages B2 and C, and B1 and C were compared. In conclusion, this study provided a reference for left atrial volume and the applicability of this technique to assess atrial overload in dogs with varying-stage MMVD.(AU)

A mensuração do volume atrial esquerdo (VAE) pode ser obtido pelo método biplanar de Simpson via ecocardiografia. Embora na medicina tal parâmetro venha sendo considerado um marcador prognóstico da sobrecarga atrial esquerda em várias cardiopatias, nos cães com degeneração mixomatosa da válvula mitral (DMVM), valvulopatia caracterizada pela sobrecarga do átrio esquerdo (AE), a avaliação da sobrecarga atrial é realizada rotineiramente apelas pela relação entre o diâmetro do AE e da artéria Aorta (Ao) (AE:Ao). Portanto, procurou-se mensurar os valores do LAV indexados à área de superfície corporal (ASC) em cães sadios e em portadores da DMVM utilizando-se do método biplanar de Simpson. Para tanto, foram avaliados 107 cães sadios (controle) e 81 portadores da DMVM nos estágios B1, B2 e C (ACVIM), sendo o VAE calculado nos momentos da diástole (d) e sístole (s) atrial utilizando o método biplanar de Simpson. Imagens bidimensionais apicais quatro (4C) e duas câmaras (2C) foram obtidas pela janela paraesternal esquerda em todos os cães. Os valores do LAV nos cães sadios foram correlacionados com o peso corporal utilizando o teste de Pearson. Para a comparação dos cães sadios com os portadores da DMVM, bem como para investigar diferenças atribuídas aos diferentes estágios da DMVM, empregou-se análise de variância (ANOVA) e o teste de Tukey. Uma correlação positiva forte foi identificada entre VAEd (r>0,77), VAEs (r>0,73) e o peso corporal dos cães sadios. O LAV indexado pela ASC calculado para os cães portadores de DMVM foi significativamente diferente (p<0,01) daquele obtido no grupo controle. Também foram observadas diferenças significativas (p<0,05) no VAE quando as classes B2 e C, e B1 e C foram comparadas. Em conclusão, este estudo fornece uma referência para o volume atrial esquerdo e a aplicabilidade dessa técnica para avaliação da sobrecarga atrial em cães com DMVM em diferentes estágios.(AU)

Pulmonary function in obese vs non-obese cats.

Obesity is a risk factor in the development of several respiratory diseases. Lung volumes tend to be decreased, especially expiratory reserve volume, increasing expiratory flow limitation during tidal breathing. Barometric whole-body plethysmography is a non-invasive pulmonary function test that allows a dynamic study of breathing patterns. The objective of this study was to compare pulmonary function variables between obese and non-obese cats through the use of barometric whole-body plethysmography. Nine normal-weight and six obese cats were placed in the plethysmograph chamber, and different respiratory variables were measured. There was a significant decrease in tidal volume per kilogram (P = 0.003), minute volume per kilogram (P = 0.001) and peak inspiratory and expiratory flows per kilogram (P = 0.001) in obese cats compared with non-obese cats. Obesity failed to demonstrate a significant increase in bronchoconstriction index variable enhanced pause (Penh), as previously reported in humans and dogs. The results show that feline obesity impairs pulmonary function in cats, although a significant increase in bronchoconstriction indexes was not observed. Non-invasive barometric whole-body plethysmography can help characterise mechanical dysfunction of the airways in obese cats.

Avaliação da pressão arterial sistêmica em cães obesos: comparação entre os métodos oscilométrico e doppler ultrassônico / Systemic blood pressure evaluation by oscillometric versus doppler ultrasonographic methods in obese dogs

A obesidade é o problema nutricional que mais acomete os cães e pode causar vários efeitos deletérios a saúde animal. No entanto, o efeito desta condição sobre a pressão arterial sistólica (PAS) em cães obesos é controverso. Os métodos indiretos de mensuração da PAS são os mais comumente utilizados na medicina veterinária para o diagnóstico da hipertensão sistêmica, por serem mais práticos e de fácil acesso. Não foram localizados na literatura estudos que tenham comparado os dois métodos para esta avaliação em cães obesos. Diante do exposto, o objetivo desse estudo foi avaliar a PAS em cães obesos, comparando os métodos indiretos de mensuração da pressão arterial, oscilométrico e doppler ultrassônico, a fim de verificar as diferenças nos valores obtidos, como também o método mais indicado para aferir a PAS em cães nesta condição. Foram avaliados 50 cães, incluindo 25 obesos com escore de condição corporal (ECC) médio de 8,42±0,50 e 25 cães com peso corporal ideal com ECC médio de 4,56±0,51. Os resultados revelaram valores superiores da PAS obtidos pelo método doppler (152±16mmHg) comparados ao oscilométrico (136±11mmHg). A análise de correspondência determinada por análise estatística multivariada demonstrou maior correspondência entre a condição corporal e o método de avaliação da PAS. Esses achados sugerem que o método indireto doppler pode aferir com mais precisão os valores de PAS em cães obesos.(AU)

Obesity is the most common nutritional problem in dogs and it can cause various harmful effects on animal health. However, the effect of this condition on systolic blood pressure (SBP) in obese dogs is controversial. The indirect method of measuring PAS is the most commonly used in veterinary medicine for the diagnosis of systemic hypertension, because it is more practical and easy to access. There is little scientific information about the comparison of the two non-invasive methods of measurement of blood pressure in obese dogs. Therefore, the objective of this study was to evaluate the SBP in obese dogs by comparing both indirect methods of measuring blood pressure, with oscillometric and doppler vascular in order to verify the differences in blood pressure values, but also the best method to assess the SBP dogs in this body score condition. The study complain blood pressure measurement of 50 dogs, with were divided in obese dogs with mean body condition score (BCS) of 8.42±0.50 (n=25) and dogs with ideal BCS of 4.56±0.51 (n=25). At comparison of blood pressure values, SBP values obtained by doppler method (152±16mmHg) were higher than the oscillometric (136±11mmHg). Correspondence analysis determined by multivariate statistical analysis showed correlation between body condition and the procedure of the SBP. These findings suggest that the indirect method doppler can better reflect the SBP in obese dogs.(AU)

The effects of different inspired oxygen fractions on gas exchange and Tei-index of myocardial performance in propofol-anesthetized dogs.

OBJECTIVE: To evaluate the influence of different inspired oxygen fractions (FiO2) on pulmonary oxygen exchange and Tei-index of myocardial performance in propofol-anesthetized dogs. STUDY DESIGN: Prospective crossover, randomized, experimental trial. ANIMALS: Eight adult dogs weighing 8.6 ± 1.8 kg. METHODS: The animals were anesthetized on five occasions, receiving either an FiO2 = 1.0 (F100), 0.8 (F80), 0.6 (F60), 0.4 (F40) or 0.21 (F21). Propofol was used for induction (6.45 ± 0.69 mgkg(-1) IV) followed by a continuous rate infusion (CRI, 0.7 mgkg(-1) minute(-1)). The dogs breathed spontaneously. The initial measurements of arterial partial pressures of oxygen (PaO2) and carbon dioxide (PaCO2), arterial hemoglobin saturation (SaO2), heart rate (HR), mean arterial pressure (MAP), cardiac index (CI), stroke index (SI), pre-ejection period (PEP) and left ventricular ejection time (LVET) were performed 30 minutes after beginning the CRI (T0) and then, at 15-minute intervals (T15-T60). From these measurements the following were calculated; alveolar oxygen partial pressure (PAO2), alveolar-arterial oxygen gradient (AaDO2), arterial oxygen partial pressure/inspired oxygen fraction ratio (PaO2/FiO2), arterial-to-alveolar oxygen tension ratio (PaO2/PAO2), respiratory index (RI), oxygen delivery (D·O2), PEP/LVET ratio, isovolumic relaxation time (IVRT) and Tei-index. RESULTS: At T30, PaCO2 in F100 was higher than in F21. The AaDO2 mean in F100 was greater than in other treatments. PaO2/FiO2 in F21 was lower than F100 and F80 at T0 and than in F80 and F60 at T15. At T15, PaO2/PAO2 and RI in F100 were higher than in F80, F60 and F21. At T30, PaO2/PAO2 in F21 was lower than in F100 and F60. At T30, PEP/LVET in F100 was higher than F80, F40 and F21, which was lower than F80 and F40. CONCLUSION: The Tei-index and cardiovascular parameters are not affected by different FiO2. CLINICAL RELEVANCE: An FiO2 of 1.0 and 0.21 impaired respiratory efficiency.

Doxorubicin induced dilated cardiomyopathy in a rabbit model: an update.

Dilated cardiomyopathy (DCM) is characterized by chamber dilation and cardiac dysfunction. Because of the poor prognosis, models are needed for the investigation of and development of new therapeutic approaches, as well as stem cell therapy. Doxorubicin (DOX), used as chemotherapeutic agent, is reported to be cumulative cardiotoxic causing DCM. The aim of the study was to investigate the onset of systolic dysfunction using echocardiography in rabbits receiving two different doses of DOX (1mg/kg twice a week and 2 mg/kg once a week). Twenty rabbits were treated with doxorubicin in two different doses for 6 weeks and compared with a control group treated with NaCl 0.9%. The effect of doxorubicin on the myocardium was investigated with histological analysis and scanning electron microscopy of left ventricle (LV), as well as in the interventricular septum (IVS) and right ventricle (RV). The results showed a high mortality rate for rabbits receiving 2 mg/kg once a week. A significant reduction in systolic function was present in animals treated with DOX after 6 weeks, with decreased ejection fraction and shortening fraction. Histology and electron microscopy revealed vacuolization, intracytoplasmic granulation, necrosis and interstitial fibrosis in LV, as well as in the IVS and RV. Doxorubicin induced changes are present in the LV, RV and IVS, and the administration at the dose of 1 mg/kg twice a week for only 6 weeks is safe and sufficient to induce DCM in rabbits.

Clinical evaluation of enalapril maleate and furosemide usage in dogs with degenerative myxomatous mitral valve, CHF functional class Ib / Avaliação clínica da utilização do maleato de enalapril e furosemida em cães com doença degenerativa mixomatosa da válvula mitral, classe funcional Ib

Degenerative myxomatous mitral valve (DMMV) is a heart disease of high incidence in small animal clinical medicine, affecting mainly older dogs and small breeds. Thus, a scientific investigation was performed in order to evaluate the clinical use of the medicines furosemide and enalapril maleate in dogs with this disease in CHF functional class Ib before and after the treatment was established. For this purpose 16 dogs with the given valve disease were used, separated into two groups: the first received furosemide (n=8) and the second received enalapril maleate (n=8) throughout 56 days. The dogs were evaluated in four stages (T0, T14, T28 and T56 day) in relation to clinical signs, hematological, biochemical and serum assessment, which included serum angiotensin converting enzyme (ACE) and aldosterone, as well as radiography, electrocardiography, Doppler-echocardiography and blood pressure. The results regarding the clinical, hematological and serum chemistry evaluations revealed no significant changes in both groups, but significant reductions in the values of ACE and aldosterone in the group receiving enalapril maleate were verified. The radiographic examination revealed reductions of VHS values and variable Pms wave of the electrocardiogram in both groups, but no changes in blood pressure values were identified. The echocardiogram showed a significant decrease of the variables LVDd/s in the studied groups and the FS percent in animals that received only enalapril. Therefore, analysis of results showed that monotherapy based on enalapril maleate showed better efficiency of symptoms control in patients with CHF functional class Ib.

A doença degenerativa mixomatosa da válvula mitral (DDMVM) é uma cardiopatia de alta incidência na clínica médica de pequenos animais, acometendo mormente cães idosos e raças de pequeno porte. Desta forma, foi realizada uma investigação científica objetivando avaliar clinicamente a utilização dos fármacos maleato de enalapril e furosemida em cães com a referida enfermidade na classe funcional Ib da ICC, antes e após a terapêutica implantada. Para isso, utilizaram-se 16 cães portadores da valvulopatia supracitada, distribuídos em dois grupos; com o primeiro recebendo furosemida (n=8) e o segundo maleato de enalapril (n=8), durante 56 dias. Os cães foram avaliados em quatro momentos (T0, T14, T28 e T56 dias) quanto aos sinais clínicos e parâmetros hematológicos e bioquímico-séricos, que incluíram concentrações séricas da enzima conversora da angiotensina (ECA) e aldosterona, como também avaliações radiográficas, eletrocardiográficas, ecodopplercardiográficas e da pressão arterial. Os resultados quanto aos parâmetros clínicos, avaliações hematológicas e bioquímicas séricas não revelaram alterações significativas em ambos os grupos, mas reduções significativas nos valores de ECA e aldosterona no grupo que recebeu o maleato de enalapril foram identificadas. Ao exame radiográfico observou-se reduções nos valores de VHS e na variável onda Pms do eletrocardiograma em ambos os grupos, mas sem alterações nos valores da pressão arterial. Por sua vez, o ecodopplercardiograma evidenciou diminuição significativa das variáveis DIVEd/s nos grupos estudados e na FEC por cento nos cães que receberam somente enalapril. Portanto, a análise dos resultados encontrados indicou que a monoterapia fundamentada no maleato de enalapril apresentou melhor eficiência no controle do quadro clínico em pacientes da classe funcional Ib da ICC.

Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: outcome in 9 cases.

OBJECTIVE: To report the outcome of partial external mitral annuloplasty in dogs with congestive heart failure (CHF) due to mitral regurgitation caused by myxomatous mitral valve degeneration (MMVD). ANIMALS, MATERIALS AND METHODS: Nine client-owned dogs with CHF due to mitral regurgitation caused by MMVD. Surgery consisted of a double row of pledget-butressed continuous suture lines placed into the left ventricle parallel and just ventral to the atrioventricular groove between the subsinuosal branch of the left circumflex coronary artery and the paraconal branch of the left coronary artery. RESULTS: Two dogs died during surgery because of severe hemorrhage. Two dogs died 12 and 36 h after surgery because of acute myocardial infarction. Three dogs were euthanized 2 and 4 weeks after surgery because of progression of CHF, 1 was euthanized 30 days after surgery for non-cardiac disease, and 1 survived for 48 months. In the 5 dogs that survived to discharge there was no significant change in the left atrium to aortic ratio with surgery (3.6 ± 0.56 before surgery; 3.1 ± 0.4 after surgery; p = 0.182), and no significant change in mitral regurgitant fraction in 4 dogs in which this measurement was made (78.7 ± 2.0% before surgery; 68.7 ± 7.5% after surgery; p = 0.09). CONCLUSIONS: Partial external mitral annuloplasty in dogs with CHF due to MMVD was associated with high perioperative mortality and most dogs that survived to discharge failed to show clinically relevant palliation from this procedure. Consequently, partial external mitral annuloplasty is not a viable option for dogs with mitral regurgitation due to MMVD that has progressed to the stage of CHF.

Cardiac function in dogs with chronic Chagas cardiomyopathy undergoing autologous stem cell transplantation into the coronary arteries.

This study assessed the effects of a single intracoronary injection of autologous stem cells on the cardiac function of dogs with Chagas cardiomyopathy. Bone-marrow-derived stem cells were delivered into the right and left coronary arteries of 5 mature dogs with mildly compromised cardiac function due to chronic Chagas cardiomyopathy. Blood pressure and electrocardiographic and echocardiographic parameters were recorded at monthly intervals for 6 mo in the 3 dogs that survived. Although no changes were observed in the electrocardiogram and blood pressure, there was a significant increase in peak velocity of aortic flow 3 mo after stem cell transplantation. Pre-ejection period, isovolumic relaxation time, and the Tei index of myocardial performance were reduced significantly 4 mo after the procedure. All significant changes persisted to the end of the study. The results suggest that the transplantation of autologous bone-marrow-derived stem cells into the coronary arteries of dogs with Chagas cardiomyopathy may have a beneficial effect but the small number of dogs studied was a limitation.

Caracterização clínica da cardiomiopatia chagásica crônica em cães / Clinical characterization of chronic chagasic cardiomyopathy in dogs

On the American continent, almost 15 million people are affected by Chagas disease, resulting in important economic and social damages. Dogs are considered to be an excellent experimental model to study Chagas' disease; as a result, in this research, the characterization of cardiovascular abnormalities was performed in dogs experimentally infected with Trypanosoma cruzi (the Colombian strain) that were at chronic stage. Thirteen adult female dogs were evaluated by electrocardiographic, echocardiographic, hematological and biochemical analyses in the chronic phase. For the electrocardiographic studies, respiratory sinus arrhythmia was the predominant rhythm during the entire research period (49.55 percent to 67 percent), with a low prevalence of right bundle branch block (0-13 percent) and first-degree atrioventricular block (0-14 percent). The spectral Doppler echocardio-graphy showed E and A mitral wave reversal (0.71±0.17), confirming the diastolic dysfunction present in all dogs. An increase in the enzymes activities was detected in the serum analysis, indicating myocardial injury by the infection. Six dogs died during the follow-up. In this way, the clinical characterization of experimentally infected dogs, as described here, increases the knowledge and allows for recognition of the behavioural modifications present in Chagas' disease in affected dogs.

No continente Americano, aproximadamente 15 milhões de pessoas são afetadas pela doença de Chagas, ocasionando importantes danos econômicos e sociais. O cão é considerado excelente modelo experimental para o estudo dessa enfermidade; assim sendo, foram caracterizadas, neste ensaio, as anormalidades cardiovasculares de 13 cães experimentalmente infectados com a cepa Colombiana do Trypanosoma cruzi, em fase crônica (1997-2004). Ao eletrocardiograma, a arritmia sinusal respiratória foi o ritmo predominante durante todo período experimental (49,55-67 por cento), com baixas prevalências de bloqueio de ramo direito (0-13 por cento) e de bloqueio atrioventricular de primeiro grau (0-14 por cento). A EcoDopplercardiografia espectral revelou inversão das ondas E e A mitral (0.71±0.17), confirmando a disfunção diastólica presente em todos os cães avaliados. O aumento da atividade enzimática sérica foi detectado, indicando agressão miocárdica pela infecção. Seis cães morreram durante o período experimental. Desta forma, a caracterização clínica dos cães experimentalmente infectados trouxe informações importantes, possibilitando reconhecer o comportamento clínico dessa importante infecção, na espécie canina.

Efeitos da perda de peso sobre os parâmetros cardíacos em cães obesos / Effects of weight loss on the cardiac parameters of obese dogs

Obesity is one of the most frequent nutritional problems in companion animals and can lead to severe health problems in dogs and cats, such as cardiovascular diseases. This research aimed to evaluate the structural and functional cardiac changes after weight loss in obese dogs. Eighteen obese healthy dogs were assigned into three different groups, according with their initial body weight: Group I (dogs up to 15 kg), Group II (dogs weighing between 15.1 and 30 kg), and Group III (dogs weighing over 30 kg). The animals were submitted to a caloric restriction weight-loss program until they lose 15 percent of the body weight. The M-mode echocardiogram, electrocardiogram, and blood pressure evaluations were performed before the diet has started and after the dogs have reached the target weight. Data showed a decrease in left ventricular free wall thickness during diastole and systole in Group III, decrease in the systolic blood pressure in Group III, and also in the mean blood pressure in Group II. It was possible to conclude that the weight loss program can reverse structural cardiac changes such as left ventricle eccentric hypertrophy in dogs weighing more than 30 kg, and decrease the arterial blood pressure in obese dogs.

A obesidade é uma das doenças nutricionais mais frequentemente observada em cães e pode provocar sérios problemas de saúde, como os distúrbios cardiovasculares. Realizou-se este estudo visando avaliar algumas das possíveis alterações estruturais e funcionais cardíacas decorrentes da correção da obesidade canina. Para isso foram utilizados 18 cães obesos divididos pelo peso corporal em Grupo I (até 15kg), Grupo II (entre 15,1 e 30 kg) e Grupo III (acima de 30 kg). Os animais foram submetidos à restrição calórica de forma a perderem 15 por cento do peso vivo. Foram realizados os exames ecocardiográfico em modo-M, eletrocardiográfico e mensuração da pressão arterial dos animais antes do início do tratamento da obesidade e após atingirem o peso meta. Os resultados revelaram que após a redução de peso ocorreram diminuições significativas da espessura da parede livre do ventrículo esquerdo durante a sístole e diástole no Grupo III, diminuição da pressão arterial sistólica no Grupo III e também da pressão arterial média no Grupo II. Assim, concluiu-se que a perda de peso pode reverter as alterações estruturais cardíacas, como a hipertrofia excêntrica do ventrículo esquerdo em cães obesos acima de 30 kg, como também reduzir a pressão arterial sistêmica em cães obesos submetidos à restrição calórica mediante administração de dieta hipocalórica.

Soroprevalência da infecção por Trypanosoma cruzi em cães de uma área rural do Estado de Mato Grosso do Sul / Seroprevalence of infection by Trypanosoma cruzi in dogs in a rural area of Mato Grosso do Sul, Brazil

Doença de Chagas é uma antropozoonose causada por Trypanosoma cruzi que tem os cães como importante reservatório da doença na América do Sul. Este trabalho teve como objetivo avaliar a ocorrência da infecção natural pelo T. cruzi em cães de uma área rural do estado de Mato Grosso do Sul, Brasil. Foram utilizados os testes de imunofluorescência indireta (IFI) e ensaio imunossorvente ligado a enzima (ELISA) em 75 cães residentes na área. Foram detectados anticorpos em 45,3 por cento (n=34) e 24,0 por cento (n=18) nos testes de IFI e ELISA, respectivamente. A real prevalência da infecção foi confirmada como 22,7 por cento (n=17) pelo critério de positividade em ambos os testes. Os resultados obtidos confirmam a infecção chagásica nos cães dessa região.

Chagas disease is an anthropozoonosis caused by Trypanosoma cruzi and dogs are considered to be one of the main reservoirs of the disease in the South America. This study evaluates the occurrence of the infection caused by T. cruzi in dogs from a rural area of Mato Grosso do Sul, Brazil. Indirect immunofluorescence test (IFI) and enzyme-linked immunosorbent assay (ELISA) was used in 75 dogs living in this area. The antibodies were detected in 45.3 percent (n=34) and 24.0 percent (n=18) with IFI and ELISA, respectively. The actual prevalence of the infection was confirmed as 22.7 percent (n=17) by the criterion of positivity in both tests. The results confirm T. cruzi infection in dogs in the region.

Effects of isoflurane on echocardiographic parameters in healthy dogs.

OBJECTIVE: To study the echocardiographic effects of isoflurane at an end-tidal concentration approximating 1.0 times the minimum alveolar concentration (MAC) in healthy unpremedicated dogs. STUDY DESIGN: Prospective experimental trial. ANIMALS: Sixteen mature mongrel dogs of either sex weighing 11.06 +/- 2.72 kg. METHODS: After performing a baseline echocardiogram in the awake animal, anesthesia was induced with increasing inspired concentrations of isoflurane via a face mask until tracheal intubation was possible. Following intubation, the end-tidal concentration was decreased to 1.4% for the rest of the anesthetic period. Serial echocardiograms were recorded at 25, 40, and 55 minutes after the end-tidal concentration was reached. RESULTS: No changes were observed in heart rate. However, significant decreases were seen in left ventricular end-diastolic diameter (Mean maximal change: 13.8%), interventricular septal thickness during systole (15.2%), interventricular septal thickening fraction (72.2%), left ventricular free wall thickening fraction (63.5%), ejection fraction (39.9%), and fractional shortening (46.7%). In addition, peak flow velocities across mitral, pulmonic, and aortic valves were significantly lower than baseline values. Decreases were also observed in end-diastolic left ventricular volume index (approximately 32.1% from the awake value), stroke index (58.2%), and cardiac index (55.3%) when compared with awake measurements. CONCLUSIONS: and clinical relevance Our results indicate that 1 x MAC isoflurane caused significant myocardial depression in healthy dogs. These changes in myocardial function need to be considered carefully when isoflurane is to be used in dogs with poor cardiovascular reserve.

Plication of the free wall of the left ventricle in dogs with doxorubicin-induced cardiomyopathy.

OBJECTIVE: To evaluate plication of the free wall of the left ventricle, which reduces the left ventricular area and volume, as a method to improve the left ventricular systolic function without cardiopulmonary bypass. ANIMALS: 8 mixed-breed adult dogs. PROCEDURE: Dilated cardiomyopathy (DCM) was induced in each dog by administration of doxorubicin (30 mg/m2, i.v., q 21 d for 168 days). Two dogs died during induction of cardiomyopathy. Plication surgery was performed in 4 dogs. Two dogs did not ondergo to surgery (control group). Values for cardiac output (CO), 2-dimensional and M-mode echocardiography, arterial blood pressure, electrocardiography, blood cell counts, and serum biochemical analyses were recorded after induction of DCM (baseline) and 1, 2, 7, 15, 21, 30, 60, 90, 120, 150, and 180 days after plication surgery. Ambulatory ECG (Holter) recordings were conducted for 24 hours on the day of surgery. RESULTS: 1 dog died after plication surgery. The remaining dogs undergoing ventricular plication had a significant improvement in CO, ejection fraction, and fractional shortening and reductions of left ventricular area and volume after surgery. Electrocardiographic and Holter recordings revealed premature ventricular complexes, which resolved without treatment during the first week after surgery. Clinical condition of the control dogs declined, and these 2 dogs died approximately 40 days after induction of cardiomyopathy. CONCLUSIONS AND CLINICAL RELEVANCE: Plication of the free wall of the left ventricle improved left ventricular systolic function in dogs with doxorubicin-induced cardiomyopathy. Additional studies are needed to evaluate its application in dogs with naturally developing DCM.